DALLAS, Oct. 19, 2017 -- AGF, Westwood, Patricia Perez-Coutts and a number of related parties wish to announce that they have resolved the AGF and Westwood actions arising from the simultaneous resignations of Ms. Perez-Coutts and four other employees of AGF in 2012, who left to join Westwood. Westwood has made a substantial payment to AGF in order to resolve these matters. Neither party admitted liability, nor any of the allegations in any of the actions.
Blake Goldring, CEO of AGF, and Brian Casey, CEO of Westwood, both believe the resolution is fair and reasonable and in the best interests of their companies and shareholders. They are pleased to put these matters behind them. The settlement does not materially impact the operations of either party and is not anticipated to affect their clients.
About Westwood
Westwood Holdings Group, Inc. provides investment management services to institutional investors, private wealth clients and financial intermediaries. With $22.6 billion in assets under management (as of June 30, 2017), the firm offers a range of investment strategies including U.S. equities, Master Limited Partnerships (MLPs), Multi-Asset, Global and Emerging Markets equities, and Global Convertible securities portfolios. Access to these strategies is available through separate accounts, the Westwood Funds family of mutual funds, UCITS funds and other pooled vehicles. Westwood benefits from significant, broad-based employee ownership and trades on the New York Stock Exchange under the symbol “WHG.” Based in Dallas, Westwood also maintains offices in Toronto, Boston, Omaha and Houston.
For more information on Westwood, please visit www.westwoodgroup.com.
For more information on the Westwood Funds®, please visit www.westwoodfunds.com.
(WHG-G)
Contact: Julie Gerron
Telephone: 214-756-6900


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



